This report contains market size and forecasts of Brain Cancer Diagnostics in Global, including the following market information:
Global Brain Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Brain Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brain Cancer Diagnostics include Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems and Hitachi, Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Brain Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Imaging Test
Lumbar Puncture
Biopsy
Molecular Testing
Others
Global Brain Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Brain Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Brain Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Brain Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Brain Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
GE Healthcare
MDxHealth
NantOmics
Biocept, Inc.
Koninklijke Philips N.V.
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems